RT @ShimaghavimiMD: @MPishvaian @drjasonstarr @TumorBoardTues @anu_iris https://t.co/aIuZhd0wJ9 Please also consider this case below also:
RT @ShimaghavimiMD: @MPishvaian @drjasonstarr @TumorBoardTues @anu_iris https://t.co/aIuZhd0wJ9 Please also consider this case below also:
RT @ShimaghavimiMD: @MPishvaian @drjasonstarr @TumorBoardTues @anu_iris https://t.co/aIuZhd0wJ9 Please also consider this case below also:
RT @ShimaghavimiMD: @MPishvaian @drjasonstarr @TumorBoardTues @anu_iris https://t.co/aIuZhd0wJ9 Please also consider this case below also:
@MPishvaian @drjasonstarr @TumorBoardTues @anu_iris https://t.co/aIuZhd0wJ9 Please also consider this case below also:
@drjasonstarr @anu_iris @TumorBoardTues @RenoHemonc @TuckerCoston @MPishvaian @pashtoonkasi #TumorBoardTuesday This is why I keep on asking https://t.co/aIuZhd0wJ9
RT @ShimaghavimiMD: Complete Response to #Pembrolizumab in #Advanced #ColonCancer Harboring Somatic #POLE F367S Mutation with #Microsatelli…
RT @ShimaghavimiMD: Complete Response to #Pembrolizumab in #Advanced #ColonCancer Harboring Somatic #POLE F367S Mutation with #Microsatelli…
Complete Response to #Pembrolizumab in #Advanced #ColonCancer Harboring Somatic #POLE F367S Mutation with #Microsatellite Stability Status: A Case Study #GITwitter #TumorBoardTuesday #Oncology #PrecisionMedicine #MEDED #genetics #CRC #MSS #Immunotherapy
Complete Response to Pembrolizumab in Advanced Colon Cancer Harboring Somatic POLE F367S Mutation with Microsatellite Stability Status: A Case Study https://t.co/UIGq78fULI https://t.co/f9a6URjZFP
New article: Complete Response to Pembrolizumab in Advanced Colon Cancer Harboring Somatic POLE F367S Mutation with Microsatellite Stability Status: A Case Study https://t.co/Lg18Cfvzyv #colorectalcancer #oncology https://t.co/AcRdIo7A6P